Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Related Articles by Review for PubMed (Select 22827608)

1.

Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS.

Wu J, Xie X, Liu Y, He J, Benitez R, Buckanovich RJ, Lubman DM.

J Proteome Res. 2012 Sep 7;11(9):4541-52. doi: 10.1021/pr300330z. Epub 2012 Aug 6.

PMID:
22827608
2.

A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.

Narimatsu H, Sawaki H, Kuno A, Kaji H, Ito H, Ikehara Y.

FEBS J. 2010 Jan;277(1):95-105. doi: 10.1111/j.1742-4658.2009.07430.x. Epub 2009 Nov 17. Review.

PMID:
19919546
3.

Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis.

Saldova R, Wormald MR, Dwek RA, Rudd PM.

Dis Markers. 2008;25(4-5):219-32. Review.

4.

Lectin-based glycoproteomic techniques for the enrichment and identification of potential biomarkers.

Abbott KL, Pierce JM.

Methods Enzymol. 2010;480:461-76. doi: 10.1016/S0076-6879(10)80020-5. Review.

PMID:
20816222
5.

Cancer biomarker discovery: lectin-based strategies targeting glycoproteins.

Clark D, Mao L.

Dis Markers. 2012;33(1):1-10. doi: 10.3233/DMA-2012-0904. Review.

6.

Fucosylated glycoproteins as markers of liver disease.

Mehta A, Block TM.

Dis Markers. 2008;25(4-5):259-65. Review.

7.

Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers.

Badr HA, Alsadek DM, Darwish AA, Elsayed AI, Bekmanov BO, Khussainova EM, Zhang X, Cho WC, Djansugurova LB, Li CZ.

Expert Rev Proteomics. 2014 Apr;11(2):227-36. doi: 10.1586/14789450.2014.897611. Epub 2014 Mar 10. Review.

PMID:
24611567
8.

Comparative glycoproteomics: approaches and applications.

Wei X, Li L.

Brief Funct Genomic Proteomic. 2009 Mar;8(2):104-13. doi: 10.1093/bfgp/eln053. Epub 2008 Dec 17. Review.

9.

Development and validation of a protein-based signature for the detection of ovarian cancer.

Kim K, Visintin I, Alvero AB, Mor G.

Clin Lab Med. 2009 Mar;29(1):47-55. doi: 10.1016/j.cll.2009.02.001. Review.

10.

Protein biomarkers in cancer: natural glycoprotein microarray approaches.

Zhao J, Patwa TH, Lubman DM, Simeone DM.

Curr Opin Mol Ther. 2008 Dec;10(6):602-10. Review.

11.

Characterization of disease-associated N-linked glycoproteins.

Tian Y, Zhang H.

Proteomics. 2013 Feb;13(3-4):504-11. doi: 10.1002/pmic.201200333. Review.

12.

Sweetening the pot: adding glycosylation to the biomarker discovery equation.

Drake PM, Cho W, Li B, Prakobphol A, Johansen E, Anderson NL, Regnier FE, Gibson BW, Fisher SJ.

Clin Chem. 2010 Feb;56(2):223-36. doi: 10.1373/clinchem.2009.136333. Epub 2009 Dec 3. Review.

13.

The sweet and sour of serological glycoprotein tumor biomarker quantification.

Kuzmanov U, Kosanam H, Diamandis EP.

BMC Med. 2013 Feb 7;11:31. doi: 10.1186/1741-7015-11-31. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk